Recombinant Human PSEN1 Protein，His

PSEN1, or Presenilin-1, is a crucial protein implicated in the pathogenesis of familial Alzheimer's disease (FAD). It forms a part of the gamma-secretase complex, an enzyme responsible for the cleavage of amyloid precursor protein (APP), leading to the production of beta-amyloid peptides. Mutations in the PSEN1 gene are associated with early-onset Alzheimer's, making it a key target for research into disease mechanisms and potential therapeutic strategies. Studies have revealed that PSEN1 mutations can alter gamma-secretase activity, impacting amyloid beta generation and contributing to neurodegeneration. Understanding the structure and function of PSEN1 is essential for developing targeted treatments. Recent advancements in recombinant protein technologies have enabled the production of PSEN1 in various systems, allowing researchers to analyze its biochemical properties, interactions with other cellular components, and role in cellular signaling pathways. By obtaining PSEN1 as a recombinant protein, scientists can conduct detailed studies on the molecular basis of Alzheimer's disease, explore the effects of specific mutations, and assess the efficacy of potential drug candidates aimed at modulating gamma-secretase activity. As research continues to unfold, PSEN1 remains a focal point in unraveling the complexities of Alzheimer’s disease and developing innovative approaches for intervention.